3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
16
Phase 3
10
Phase 2
7
Phase 4
2
Phase 1/2
1
Phase 1
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Liver Neoplasms
4
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Neoplasms
1
Klatskin Tumor
1
Esophageal Neoplasms
1
Cancer Pain
1
Bile Duct Neoplasms
1
Agnosia
1
Interventions
Sorafenib
9
gadolinium ethoxybenzyl DTPA
4
Hepatectomy
4
lenvatinib
3
entecavir
3
Sufentanil
3
Ribavirin
3
Propranolol
3
Lamivudine
3
sofosbuvir-velpatasvir drug combination
2
peginterferon alfa-2a
2
gadoterate meglumine
2
atezolizumab
2
Thrombectomy
2
Tenofovir
2
Sevoflurane
2
Radiofrequency Ablation
2
Laparoscopy
2
Esketamine
2
Chemoembolization, Therapeutic
2
Bevacizumab
2
xihuang
1
stronger neominophagen C
1
ledipasvir
1
huaier
1
halofantrine
1
gadoteridol
1
gadodiamide
1
gadobutrol
1
gadobenic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Hepatocellular
×
Radiofrequency Ablation
×
Clear all
NCT00554905
2009-02-10
RFA and TACE
Sun Yat-sen University
Phase 4
Unknown
180 enrolled
NCT00556803
2008-11-18
TACE-RFA
Sun Yat-sen University
Phase 4
Unknown
120 enrolled